25 Nov, EOD - Indian

SENSEX 80109.85 (1.25)

Nifty 50 24221.9 (1.32)

Nifty Bank 52207.5 (2.10)

Nifty IT 43618.15 (0.66)

Nifty Midcap 100 55900.55 (1.61)

Nifty Next 50 69342.7 (1.95)

Nifty Pharma 22177.05 (0.98)

Nifty Smallcap 100 18115.85 (2.03)

25 Nov, EOD - Global

NIKKEI 225 38780.14 (1.30)

HANG SENG 19150.99 (-0.41)

S&P 5978.73 (0.07)

Login/Signup
LOGIN HERE
Cancel

Entero Healthcare Solutions Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 544122 | NSE Symbol : ENTERO | ISIN : INE010601016 | Industry : Retail |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
06-Nov-2024 12-Nov-2024 Quarterly Results Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30 2024. Outcome of Board Meeting held on November 12, 2024 (As Per Bse Announcement Dated on 12.11.2024)
08-Aug-2024 14-Aug-2024 Quarterly Results Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended June 30 2024
02-Aug-2024 02-Aug-2024 AGM Submission of outcome of Board Meeting held on August 02, 2024
28-Jun-2024 28-Jun-2024 Others Outcome of Board Meeting held on June 28, 2024 Entero Healthcare Solutions Limited ('Entero') has informed the Exchange about acquisition of Devi Pharma Wellness Private Limited approved by the Board of Entero at its meeting held on June 28, 2024.
22-May-2024 29-May-2024 Accounts Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31 2024 Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2024 Outcome of Board Meeting held on May 29, 2024 (As Per BSE Announcement Dated on 29.05.2024) Revised outcome due type error in Annexure E (As Per BSE Announcement Dated on 30.05.2024)
06-May-2024 06-May-2024 Acquisitions The Board of Directors of Entero Healthcare Solutions Limited ('Company') has approved, inter-alia, to execute the definitive agreements to acquire 80% paid-up equity share capital of Avenir Lifecare Pharma Private Limited ('ALPPL') at their meeting held today i.e. 6th May 2024. The Board of Directors of Entero Healthcare Solutions Limited ('Company') has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held on May 06, 2024.
28-Feb-2024 08-Mar-2024 Quarterly Results Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2023. Submission of Financial Results for the Quarter and Nine Months ended December 31, 2023 Outcome of Board Meeting held on March 08, 2024 Acquisition of balance 12,00,000 Equity Shares (representing 15% paid up equity share capital) of Getwell Medicare Solution Private Limited, the subsidiary company, from the erstwhile promoters. (As Per BSE Announcement Dated on 08/03/2024)